Power Knee Launches – World’s 1st Actively Powered Microprocessor Prosthetic Knee for Above-Knee Amputations

"Smart" Prosthesis Uses Advanced Algorithms to Detect Human Movementand Provide Real-Time, Active Powered Assistance

POWER KNEETM, the world’s first actively powered microprocessor prosthetic knee for people with above-knee amputation or limb difference reports Össur (Nasdaq: OSSR), a global innovation leader in the orthotics and prosthetics (O&P) industry with a rich history of pioneering breakthroughs.

POWER KNEE is groundbreaking bionic technology — a motor-powered “smart” prosthesis that uses advanced algorithms to detect human movement patterns, learns and adjusts to its wearer’s speed and cadence in real-time.

The POWER KNEE creates motion by providing active powered assistance while distinguishing whether its wearer is walking on varying surfaces, inclines, or declines, or sitting and standing. When ascending stairs, the wearer is able to perform a more natural “step-over-step” pattern, and experience more controlled resistance when descending stairs or ramps.

“No other knee thinks, acts or behaves remotely like the new, next-generation POWER KNEE,” said Jon Sigurdsson, President and CEO of Össur. “While other microprocessor knees are “passive” in nature, we have always considered the restoration of power – which is fundamental to the biomechanical systems that move all human bodies – to be a critical function that was lacking in other prosthetic solutions for amputees. The POWER KNEE delivers on that promise and represents an extraordinary milestone in mobility for people with limb loss and limb difference.”

According to Mr. Sigurdsson, the POWER KNEE’s motor-powered energy helps encourage more symmetrical motion and enhance its wearer’s endurance by helping them conserve their own energy, a consideration that can be especially critical for people with lower-limb loss or limb difference.

“For over 15 years, Össur has championed actively powered knee technology, continually expanding the boundary of what was possible in prosthetics because we saw the incredible potential for those with limb loss. The new POWER KNEE is a truly transformative solution that allows its users to accomplish things that were unimaginable before,” Mr. Sigurdsson said. “The era of powered prosthetics is here, and it will revolutionize what the world expects from a prosthesis.”

SourceÖssur

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”